A. Chetanneau

564 total citations
18 papers, 414 citations indexed

About

A. Chetanneau is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Surgery. According to data from OpenAlex, A. Chetanneau has authored 18 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in A. Chetanneau's work include Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). A. Chetanneau is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). A. Chetanneau collaborates with scholars based in France, United States and Germany. A. Chetanneau's co-authors include P Peltier, J.F. Chatal, M∘ Pinaud, Rémi Souron, Jacques Barbet, Anne Gruaz‐Guyon, M Delaage, J M Le Doussal, Paul‐Antoine Lehur and Meghan Martin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

A. Chetanneau

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Chetanneau France 12 234 75 74 57 56 18 414
U Büll Germany 11 286 1.2× 37 0.5× 29 0.4× 45 0.8× 39 0.7× 63 516
Eva A. Wegner Australia 6 172 0.7× 72 1.0× 36 0.5× 60 1.1× 11 0.2× 17 325
C. Gustafson Sweden 7 79 0.3× 39 0.5× 21 0.3× 52 0.9× 12 0.2× 12 385
Sandra Brennan United States 15 458 2.0× 15 0.2× 92 1.2× 109 1.9× 43 0.8× 25 810
Jacek Kuśmierek Poland 13 163 0.7× 104 1.4× 71 1.0× 195 3.4× 5 0.1× 65 538
G Galli Italy 12 154 0.7× 122 1.6× 44 0.6× 122 2.1× 3 0.1× 41 520
Felix Erdfelder Germany 12 27 0.1× 46 0.6× 44 0.6× 27 0.5× 22 0.4× 22 381
Ronald Lorig United States 12 121 0.5× 103 1.4× 37 0.5× 127 2.2× 4 0.1× 21 539
R Pálvölgyi United States 7 73 0.3× 127 1.7× 53 0.7× 46 0.8× 9 0.2× 25 367
Norihiko Kume Japan 13 141 0.6× 52 0.7× 39 0.5× 117 2.1× 3 0.1× 54 445

Countries citing papers authored by A. Chetanneau

Since Specialization
Citations

This map shows the geographic impact of A. Chetanneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Chetanneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Chetanneau more than expected).

Fields of papers citing papers by A. Chetanneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Chetanneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Chetanneau. The network helps show where A. Chetanneau may publish in the future.

Co-authorship network of co-authors of A. Chetanneau

This figure shows the co-authorship network connecting the top 25 collaborators of A. Chetanneau. A scholar is included among the top collaborators of A. Chetanneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Chetanneau. A. Chetanneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Thomas, Clément, et al.. (2022). 18F-NaF PET/CT in Presumed Aseptic Pseudarthrosis after Spinal Fusion: Correlation with Findings at Revision Surgery and Intraoperative Cultures. SHILAP Revista de lepidopterología. 21(4). 302–313. 3 indexed citations
2.
3.
Wolff, Bruce G., John S. Bolton, Richard P. Baum, et al.. (1998). Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT®-Tc), a totally human monoclonal antibody. Diseases of the Colon & Rectum. 41(8). 953–962. 13 indexed citations
4.
Chetanneau, A., Jacques Barbet, P Peltier, et al.. (1994). Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. Nuclear Medicine Communications. 15(12). 972–980. 24 indexed citations
5.
Doussal, J M Le, A. Chetanneau, Anne Gruaz‐Guyon, et al.. (1993). Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.. PubMed. 34(10). 1662–71. 68 indexed citations
6.
Chetanneau, A., et al.. (1992). MIBG Scintigraphy of a Patient with Pheochromocytoma on Labetalol Therapy. Clinical Nuclear Medicine. 17(4). 308–311. 8 indexed citations
7.
Morais, João, et al.. (1992). Anti-??HCG abdominopelvic immunoscintigraphy in patients with resistant gestational trophoblastic disease. Nuclear Medicine Communications. 13(6). 464–466. 2 indexed citations
8.
Peltier, P, et al.. (1992). Comparison of technetium-99mC and phytate aerosol in ventilation studies. European Journal of Nuclear Medicine and Molecular Imaging. 19(5). 349–54. 15 indexed citations
9.
Vuillez, J.-P., et al.. (1992). Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.. The Journal of Clinical Endocrinology & Metabolism. 74(1). 157–163. 25 indexed citations
10.
Pinaud, M., et al.. (1991). Effets du Diprivan® sur le débit sanguin cérébral, la pression intracrânienne et l'activité métabolique cérébrale chez le traumatisé crânien. Annales Françaises d Anesthésie et de Réanimation. 10(1). 2–9. 4 indexed citations
11.
Vuillez, J.-P., P Peltier, Frédéric Dubois, et al.. (1991). Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.. PubMed. 32(2). 221–7. 11 indexed citations
12.
Chetanneau, A., Richard P. Baum, Paul‐Antoine Lehur, et al.. (1990). Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab?)2 fragments. European Journal of Nuclear Medicine and Molecular Imaging. 17(5). 223–229. 6 indexed citations
13.
Peltier, P, P. De Faucal, A. Chetanneau, & J.F. Chatal. (1990). Comparison of technetium-99m aerosol and krypton-81m in ventilation studies for the diagnosis of pulmonary embolism. Nuclear Medicine Communications. 11(9). 631–638. 28 indexed citations
14.
Curtet, C., J.-P. Vuillez, Gregory B. Daniel, et al.. (1990). Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody. European Journal of Nuclear Medicine and Molecular Imaging. 17(6-8). 299–304. 12 indexed citations
15.
Pinaud, M∘, et al.. (1990). Effects of Propofol on Cerebral Hemodynamics and Metabolism in Patients with Brain Trauma. Anesthesiology. 73(3). 404–409. 100 indexed citations
16.
Chetanneau, A., Paul‐Antoine Lehur, P Peltier, et al.. (1989). Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. European Journal of Nuclear Medicine and Molecular Imaging. 15(6). 302–306. 11 indexed citations
17.
Chetanneau, A., et al.. (1988). [Difficulties of the X-ray computed tomographic diagnosis of pelvic tumor recurrence: comparison with other medical imaging techniques (ultrasonography, immunoscintigraphy)].. PubMed. 31(7-8). 426–32. 2 indexed citations
18.
Chatal, Jean‐François, P. Fumoleau, Philippe Thédrez, et al.. (1987). Immunoscintigraphy of recurrences of gynecologic carcinomas.. PubMed. 28(12). 1807–19. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U Büll Breakdown of academic impact, for papers by Eva A. Wegner Breakdown of academic impact, for papers by C. Gustafson Breakdown of academic impact, for papers by Sandra Brennan Breakdown of academic impact, for papers by Jacek Kuśmierek Breakdown of academic impact, for papers by G Galli Breakdown of academic impact, for papers by Felix Erdfelder Breakdown of academic impact, for papers by Ronald Lorig Breakdown of academic impact, for papers by R Pálvölgyi Breakdown of academic impact, for papers by Norihiko Kume
Rankless by CCL
2026